← Back

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

This grant encourages investigators to conduct translational activities and clinical feasibility studies for therapeutic and diagnostic devices targeting nervous or neuromuscular disorders. It funds prototype implementation, non-clinical safety and efficacy testing, design verification, regulatory submissions, and clinical feasibility studies to gather device performance data not obtainable through bench or animal work.

Amount
Not stated
Type
Grant

Key facts

Key facts for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
AmountNot stated
IssuerNational Institutes of Health
Who can applySmall businesses, companies, universities and 7 more
SectorsEdTech · HealthTech
DeadlineCloses 28 Jan 2028

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

  1. 91 days agoagentImported from the official source